Literature DB >> 24096869

Hsp90 chaperones PPARγ and regulates differentiation and survival of 3T3-L1 adipocytes.

M T Nguyen1, P Csermely, C Sőti.   

Abstract

Adipose tissue dysregulation has a major role in various human diseases. The peroxisome proliferator-activated receptor-γ (PPARγ) is a key regulator of adipocyte differentiation and function, as well as a target of insulin-sensitizing drugs. The Hsp90 chaperone stabilizes a diverse set of signaling 'client' proteins, thereby regulates various biological processes. Here we report a novel role for Hsp90 in controlling PPARγ stability and cellular differentiation. Specifically, we show that the Hsp90 inhibitors geldanamycin and novobiocin efficiently impede the differentiation of murine 3T3-L1 preadipocytes. Geldanamycin at higher concentrations also inhibits the survival of both developing and mature adipocytes, respectively. Further, Hsp90 inhibition disrupts an Hsp90-PPARγ complex, leads to the destabilization and proteasomal degradation of PPARγ, and inhibits the expression of PPARγ target genes, identifying PPARγ as an Hsp90 client. A similar destabilization of PPARγ and a halt of adipogenesis also occur in response to protein denaturing stresses caused by a single transient heat-shock or proteasome inhibition. Recovery from stress restores PPARγ stability and adipocyte differentiation. Thus, our findings reveal Hsp90 as a critical stress-responsive regulator of adipocyte biology and offer a potential therapeutic target in obesity and the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24096869      PMCID: PMC3824595          DOI: 10.1038/cdd.2013.129

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  58 in total

1.  Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.

Authors:  Massimiliano Caprio; Bruno Fève; Aurélie Claës; Say Viengchareun; Marc Lombès; Maria-Christina Zennaro
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

2.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids.

Authors:  Z Wu; N L Bucher; S R Farmer
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

3.  Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality.

Authors:  Sheng Zhong Duan; Christine Y Ivashchenko; Steven E Whitesall; Louis G D'Alecy; Damon C Duquaine; Frank C Brosius; Frank J Gonzalez; Charles Vinson; Melissa A Pierre; David S Milstone; Richard M Mortensen
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

4.  Dynamics of fat cell turnover in humans.

Authors:  Kirsty L Spalding; Erik Arner; Pål O Westermark; Samuel Bernard; Bruce A Buchholz; Olaf Bergmann; Lennart Blomqvist; Johan Hoffstedt; Erik Näslund; Tom Britton; Hernan Concha; Moustapha Hassan; Mikael Rydén; Jonas Frisén; Peter Arner
Journal:  Nature       Date:  2008-05-04       Impact factor: 49.962

5.  Critical regulation of TGFbeta signaling by Hsp90.

Authors:  Katharine H Wrighton; Xia Lin; Xin-Hua Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

Review 6.  Fat and beyond: the diverse biology of PPARgamma.

Authors:  Peter Tontonoz; Bruce M Spiegelman
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

7.  HSP72 protects against obesity-induced insulin resistance.

Authors:  Jason Chung; Anh-Khoi Nguyen; Darren C Henstridge; Anna G Holmes; M H Stanley Chan; Jose L Mesa; Graeme I Lancaster; Robert J Southgate; Clinton R Bruce; Stephen J Duffy; Ibolya Horvath; Ruben Mestril; Matthew J Watt; Philip L Hooper; Bronwyn A Kingwell; Laszlo Vigh; Andrea Hevener; Mark A Febbraio
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-25       Impact factor: 11.205

8.  Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.

Authors:  Satoshi Kokura; Satoko Adachi; Emiko Manabe; Katsura Mizushima; Takeshi Hattori; Toshimitsu Okuda; Nami Nakabe; Osamu Handa; Tomohisa Takagi; Yuji Naito; Norimasa Yoshida; Toshikazu Yoshikawa
Journal:  Int J Hyperthermia       Date:  2007-05       Impact factor: 3.914

9.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

10.  PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.

Authors:  Gema Medina-Gomez; Sarah L Gray; Laxman Yetukuri; Kenju Shimomura; Sam Virtue; Mark Campbell; R Keira Curtis; Mercedes Jimenez-Linan; Margaret Blount; Giles S H Yeo; Miguel Lopez; Tuulikki Seppänen-Laakso; Frances M Ashcroft; Matej Oresic; Antonio Vidal-Puig
Journal:  PLoS Genet       Date:  2007-04-27       Impact factor: 5.917

View more
  22 in total

1.  Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target.

Authors:  Xiao-Yi Zeng; Hao Wang; Fang Bai; Xiu Zhou; Song-Pei Li; Lu-Ping Ren; Ruo-Qiong Sun; Charlie C L Xue; Hua-Liang Jiang; Li-Hong Hu; Ji-Ming Ye
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

2.  Heat Shock Protein 90 Modulates Lipid Homeostasis by Regulating the Stability and Function of Sterol Regulatory Element-binding Protein (SREBP) and SREBP Cleavage-activating Protein.

Authors:  Yen-Chou Kuan; Tsutomu Hashidume; Takahiro Shibata; Koji Uchida; Makoto Shimizu; Jun Inoue; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

3.  Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease.

Authors:  Matthew C Wheeler; Nicholas Gekakis
Journal:  J Lipid Res       Date:  2014-06-13       Impact factor: 5.922

4.  FAM172A supervises ER (endoplasmic reticulum) stress-triggered autophagy in the epidural fibrosis process.

Authors:  Yufeng Zheng; Dianzhong Zhang; Le Su; Yanhua Wen; Yucai Wang
Journal:  JOR Spine       Date:  2022-05-01

5.  Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts.

Authors:  Huan Yang; Hongtao Shen; Jing Li; Kristin I Stanford; Lian-Wang Guo
Journal:  Cell Signal       Date:  2020-08-02       Impact factor: 4.315

Review 6.  Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51.

Authors:  Judith Toneatto; Nancy L Charó; Natalia M Galigniana; Graciela Piwien-Pilipuk
Journal:  Adipocyte       Date:  2015-05-13       Impact factor: 4.534

Review 7.  Koschei the immortal and anti-aging drugs.

Authors:  M V Blagosklonny
Journal:  Cell Death Dis       Date:  2014-12-04       Impact factor: 8.469

8.  C-terminus of HSC70-Interacting Protein (CHIP) Inhibits Adipocyte Differentiation via Ubiquitin- and Proteasome-Mediated Degradation of PPARγ.

Authors:  Jung-Hoon Kim; Soyeon Shin; Jinho Seo; Eun-Woo Lee; Manhyung Jeong; Min-Sik Lee; Hyun-Ji Han; Jaewhan Song
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

9.  Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation.

Authors:  Sébastien Desarzens; Wan-Hui Liao; Caterina Mammi; Massimiliano Caprio; Nourdine Faresse
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

10.  Heat Shock Protein Augmentation of Angelica gigas Nakai Root Hot Water Extract on Adipogenic Differentiation in Murine 3T3-L1 Preadipocytes.

Authors:  Wenchie Marie L Lumbera; Joseph Dela Cruz; Seung-Hak Yang; Seong Gu Hwang
Journal:  Asian-Australas J Anim Sci       Date:  2016-03-01       Impact factor: 2.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.